Cynapsus Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended 2015
Mar 09, 2016 21:15 pm UTC| Business
TORONTO, March 09, 2016 -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use, sublingual...
Allied Motion Reports 2015 Fourth Quarter and Full Year Results
Mar 09, 2016 21:15 pm UTC| Business
Generated $20.1 million of cash from operations in 2015Total debt, net of cash, reduced $14.2 million to $47.5 million in 2015Gaining traction with solution-based, integrated offerings AMHERST, N.Y., March 09, 2016 --...
Mar 09, 2016 21:15 pm UTC| Business
CAMP HILL, Pa., March 09, 2016 -- Global industrial company Harsco Corporation (NYSE:HSC) announced today the five-year contract extension of its steel mill services in Belgium at the Châtelet site of Aperam, a leading...
Crown Castle Appoints New Chief Financial Officer
Mar 09, 2016 21:15 pm UTC| Business
HOUSTON, March 09, 2016 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today it has appointed Daniel Schlanger as Chief Financial Officer, effective June 1, 2016, with Mr. Schlanger joining...
Mar 09, 2016 21:15 pm UTC| Business
MCLEANSVILLE, N.C., March 09, 2016 -- February 22, 2016 marked the date of the ribbon cutting ceremony for the official opening of the new office located in Metro Manila. Attorney Elmer Pedregosa, local counsel, gave...
MidwayUSA Returns as Presenting Sponsor of 2016 NRA Bianchi Cup
Mar 09, 2016 21:11 pm UTC| Business
COLUMBIA, Mo., March 9, 2016 -- For the eighth consecutive year, MidwayUSA will return as the presenting sponsor of the 2016 National Action Pistol Championship. Better known as the NRA Bianchi Cup for its world famous...
Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 09, 2016 21:10 pm UTC| Business
PRINCETON, N.J., March 09, 2016 -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products,...